Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.
The British journal of dermatology·2019
Estimating the relative risk of developing melanoma in INK4A carriers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2004
Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
The influence of hospital volume on survival after resection for lung cancer.
The New England journal of medicine·2001
Age and adjuvant chemotherapy use after surgery for stage III colon cancer.
Journal of the National Cancer Institute·2001
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
The expanding role of Cav3 channels in glioblastoma.
Trends in pharmacological sciences·2026
Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis.
International urology and nephrology·2026
Interaction of circular RNAs with splicing factors in cervical cancer: Modulation, interplay and theranostics (Review).
Molecular medicine reports·2026
Margin-enriched CD4+ central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma.
International journal of biological sciences·2026